Bienville Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,421
| Closed | -$448K | – | 208 |
|
|
2019
Q2 | $448K | Hold |
3,421
| – | – | 0.05% | 77 |
|
|
2019
Q1 | $462K | Hold |
3,421
| – | – | 0.05% | 69 |
|
|
2018
Q4 | $333K | Buy |
3,421
+1,421
| +71% | +$138K | 0.06% | 89 |
|
|
2018
Q3 | $278K | Hold |
2,000
| – | – | 0.02% | 78 |
|
|
2018
Q2 | $248K | Sell |
2,000
-39
| -2% | -$4.84K | 0.02% | 97 |
|
|
2018
Q1 | $227K | Sell |
2,039
-1,470
| -42% | -$164K | 0.04% | 102 |
|
|
2017
Q4 | $420K | Buy |
3,509
+75
| +2% | +$8.98K | 0.07% | 102 |
|
|
2017
Q3 | $482K | Buy |
3,434
+1
| +0% | +$140 | 0.08% | 74 |
|
|
2017
Q2 | $418K | Sell |
3,433
-667
| -16% | -$81.2K | 0.12% | 81 |
|
|
2017
Q1 | $497K | Buy |
4,100
+700
| +21% | +$84.9K | 0.12% | 67 |
|
|
2016
Q4 | $416K | Hold |
3,400
| – | – | 0.09% | 72 |
|
|
2016
Q3 | $417K | Hold |
3,400
| – | – | 0.11% | 74 |
|
|
2016
Q2 | $397K | Buy |
+3,400
| New | +$397K | 0.11% | 65 |
|
|
2015
Q1 | – | Sell |
-3,800
| Closed | -$703K | – | 89 |
|
|
2014
Q4 | $703K | Buy |
+3,800
| New | +$703K | 0.58% | 24 |
|